What is CRISPR Therapeutics's short- term investments?

CRISPR Therapeutics (CRSP) reported short- term investments of $2.02B in Q1 2026.

How has CRISPR Therapeutics's short- term investments changed year-over-year?

CRISPR Therapeutics's short- term investments increased by 24.6% year-over-year, from $1.62B to $2.02B.

What is the long-term trend for CRISPR Therapeutics's short- term investments?

Over 5 years (2020 to 2025), CRISPR Therapeutics's short- term investments has grown at a 25.6% compound annual growth rate (CAGR), from $521.71M to $1.63B.

CRISPR Therapeutics CRSP Short- term Investments

Short- term Investments at other companies

CG OncologyCGON

——

Regeneron PharmaceuticalsREGN

——

PTC TherapeuticsPTCT

——

Protagonist TherapeuticsPTGX

——

Gilead SciencesGILD

——

Johnson & JohnsonJNJ

——

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's short- term investments?: CRISPR Therapeutics (CRSP) reported short- term investments of $2.02B in Q1 2026.
How has CRISPR Therapeutics's short- term investments changed year-over-year?: CRISPR Therapeutics's short- term investments increased by 24.6% year-over-year, from $1.62B to $2.02B.
What is the long-term trend for CRISPR Therapeutics's short- term investments?: Over 5 years (2020 to 2025), CRISPR Therapeutics's short- term investments has grown at a 25.6% compound annual growth rate (CAGR), from $521.71M to $1.63B.